RecruitingNCT06892717

Caregiver Burden in Parkinson's Disease

Caregiver Burden and Associated Factors in Parkinson's Disease


Sponsor

Beylikduzu State Hospital

Enrollment

43 participants

Start Date

Feb 10, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Primary caregivers of patients diagnosed with idiopathic Parkinson's disease will be included in the study. A total of 43 participants will be recruited. At the beginning of the study, demographic data and clinical characteristics of the patients, including disease stage, history of falls, presence of fractures, presence and severity of pain, comorbidities, and medication use, will be recorded. Subsequently, caregivers' age, gender, occupation, relationship to the patient, caregiving duration, and their own comorbidities will be assessed. Sleep problems will be evaluated using the Insomnia Severity Index (ISI), while symptoms related to depression and anxiety will be assessed with the Hospital Anxiety and Depression Scale (HADS). Caregiver burden will be examined using the Zarit Caregiver Burden Scale.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Inclusion Criteria5

  • Age between 40-80 years
  • Diagnosed with Parkinson's disease, Hoehn and Yahr stage 2-5
  • Requires assistance in daily activities
  • Informal caregiver providing care (unpaid, typically a family member such as a spouse or child)
  • Caregiver has sufficient proficiency in Turkish to understand and respond to the study questions

Exclusion Criteria6

  • Presence of any additional neurodegenerative disease other than Parkinson's disease
  • Diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
  • Advanced heart failure classified as New York Heart Association (NYHA) Class IV (symptoms at rest)
  • Active cancer disease
  • History of stroke causing limitations in daily life
  • Immobility due to reasons other than Parkinson's disease

Interventions

OTHER

Locations(1)

Beylikdüzü State Hospital

Istanbul, Beylikdüzü, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06892717


Related Trials